Exosomes for Hairloss Treatment

Exclusion Criteria

• •1. People with patchy or diffuse baldness, syphilitic alopecia, scarring alopecia, malnutrition, chemotherapy/radiotherapy-induced hair loss.
• •2. Those with a combination of diseases that have an impact on hair growth.
• •3. Use of medications, medicated shampoos, or hair care products that may interfere with efficacy evaluation within 3 months prior to screening (oral administration of therapeutic agents for androgenetic alopecia must be discontinued for at least 6 months).
• •4. Have received scalp radiation and/or laser or surgical therapy within 3 months prior to screening.
• •5. Participated or are participating in a interventional clinical trial within 3 months.
• •6. Persons with a history of hereditary alopecia areata.
• •7. Women who are pregnant or breastfeeding, or male/female subjects whose own/partner's pregnancy is planned within 6 months.
• •8. Have undergone hair transplantation in the previous 24 months.
• •9. Individuals testing positive for active infectious diseases or carriers of communicable pathogens.
• •10. Those with keloid, keloid-prone or hyperplastic scarring.
• •11. Those who, in the opinion of the investigator, are otherwise unfit to participate in this clinical study.